Anthony S. Thornley, Director at TRANSDEL PHARMACEUTICALS INC (TDLP.OB), bought 4,200 shares at $1.74 ($7K) on 2008-06-27, disclosed to the SEC on 2008-07-01.
Open-market purchase of $7k TDLP.OB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ELY | SELL | 2017-11-01 | $101K | — | Filing → |
| ELY | SELL | 2017-05-09 | $136K | — | Filing → |
| CAVM | SELL | 2017-02-07 | $1.6M | — | Filing → |